Equity investors in China are taking a flyer on a strategy that hasn’t worked in years, speculating small caps will soar on the country’s sweeping plans to invigorate its fastest-growing firms.
China’s three most popular exchange-traded funds in 2018 all track smaller stocks, luring some $3 billion in net new assets, data compiled by Bloomberg show. While that’s a tiny slice of the nation’s $7.4 trillion equity market, it’s nearly 60 percent of all the cash that’s gone into stock funds trading in Shanghai or Shenzhen, according to the data.
Small caps have borne the brunt of China’s deleveraging campaign since the 2015 stock bubble burst on concern they would struggle to cope with soaring funding costs. Though the ChiNext is once again down for the year, it’s holding up better than a gauge tracking blue chips, a small win after it largely missed out on a two-year global bull market.
“China’s push to encourage domestic listings of unicorn companies has triggered interest in small caps,” said Patrick Dai, head of A-share research at Macquarie Commodities and Global Markets Group in Shanghai. “Investors are positioning for a potential rally in new-economy sectors because those listings would boost market sentiment.”
Top Blue Chip Stocks To Watch Right Now: Intec Pharma Ltd.(NTEC)
Advisors' Opinion:- [By Joseph Griffin]
Get a free copy of the Zacks research report on Intec Pharma (NTEC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Get a free copy of the Zacks research report on Intec Pharma (NTEC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Headlines about Intec Pharma (NASDAQ:NTEC) have trended somewhat positive recently, Accern Sentiment reports. Accern scores the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Intec Pharma earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news coverage about the biotechnology company an impact score of 45.4513319646459 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
- [By Joseph Griffin]
Intec Pharma (NASDAQ:NTEC) has been assigned a $15.00 target price by Oppenheimer in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the biotechnology company’s stock. Oppenheimer’s price objective would indicate a potential upside of 185.71% from the company’s current price.
- [By Ethan Ryder]
Media stories about Intec Pharma (NASDAQ:NTEC) have been trending somewhat positive on Wednesday, according to Accern Sentiment. The research group ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Intec Pharma earned a coverage optimism score of 0.18 on Accern’s scale. Accern also assigned news stories about the biotechnology company an impact score of 45.6707447165993 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
Top Blue Chip Stocks To Watch Right Now: Synopsys, Inc.(SNPS)
Advisors' Opinion:- [By Joseph Griffin]
Champlain Investment Partners LLC boosted its position in Synopsys, Inc. (NASDAQ:SNPS) by 3.9% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 686,287 shares of the semiconductor company’s stock after purchasing an additional 25,685 shares during the period. Champlain Investment Partners LLC owned about 0.46% of Synopsys worth $57,127,000 as of its most recent filing with the SEC.
- [By Ethan Ryder]
Royal London Asset Management Ltd. purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 60,026 shares of the semiconductor company’s stock, valued at approximately $5,137,000.
- [By Logan Wallace]
These are some of the news headlines that may have effected Accern Sentiment’s analysis:
Get Synopsys alerts: Synopsys, Inc. (SNPS) Receives Average Rating of “Buy” from Brokerages (americanbankingnews.com) Free Research Report as Applied Materials' Revenues Grew 28.8%; Adjusted EPS Surged 54.4% (finance.yahoo.com) Synopsys IC Validator Certified by Samsung Foundry for 7nm Signoff Physical Verification (prnewswire.com) Synopsys Fusion Technology Enables Lower Power, Smaller Area, and Higher Performance on Samsung Foundry 7LPP Process with EUV (prnewswire.com) Synopsys Announces New Release of LucidShape Software for Automotive Lighting Design and Analysis (finance.yahoo.com)A number of equities analysts recently commented on SNPS shares. KeyCorp reaffirmed an “overweight” rating and set a $110.00 price target (up from $106.00) on shares of Synopsys in a research note on Thursday, February 22nd. Royal Bank of Canada reaffirmed a “buy” rating on shares of Synopsys in a research note on Friday, February 23rd. Zacks Investment Research cut shares of Synopsys from a “hold” rating to a “strong sell” rating in a research note on Monday, February 26th. BidaskClub cut shares of Synopsys from a “hold” rating to a “sell” rating in a research note on Tuesday, February 27th. Finally, ValuEngine raised shares of Synopsys from a “hold” rating to a “buy” rating in a research report on Thursday, April 12th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. Synopsys presently has an average rating of “Buy” and an average target price of $102.71.
- [By Motley Fool Transcribing]
Synopsys (NASDAQ:SNPS) Q3 2018 Earnings Conference CallAug. 22, 2018 5:00 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
Top Blue Chip Stocks To Watch Right Now: tronc, Inc. (TRNC)
Advisors' Opinion:- [By Lisa Levin]
Companies Reporting After The Bell Booking Holdings Inc. (NASDAQ: BKNG) is projected to post quarterly earnings at $10.67 per share on revenue of $2.87 billion. CenturyLink, Inc. (NYSE: CTL) is expected to post quarterly earnings at $0.19 per share on revenue of $6.00 billion. Albemarle Corporation (NYSE: ALB) is projected to post quarterly earnings at $1.21 per share on revenue of $803.36 million. Spectra Energy Partners, LP (NYSE: SEP) is estimated to post quarterly earnings at $0.81 per share on revenue of $751.57 million. IAC/InterActiveCorp (NASDAQ: IAC) is expected to post quarterly earnings at $0.8 per share on revenue of $923.80 million. Open Text Corporation (NASDAQ: OTEX) is projected to post quarterly earnings at $0.62 per share on revenue of $691.75 million. Tutor Perini Corporation (NYSE: TPC) is expected to post quarterly earnings at $0.29 per share on revenue of $1.09 billion. Twenty-First Century Fox, Inc. (NASDAQ: FOXA) is projected to post quarterly earnings at $0.54 per share on revenue of $7.41 billion. ICU Medical, Inc. (NASDAQ: ICUI) is estimated to post quarterly earnings at $1.84 per share on revenue of $346.28 million. TechnipFMC plc (NYSE: FTI) is expected to post quarterly earnings at $0.33 per share on revenue of $3.13 billion. Synaptics Incorporated (NASDAQ: SYNA) is projected to post quarterly earnings at $0.91 per share on revenue of $401.76 million. The Dun & Bradstreet Corporation (NYSE: DNB) is expected to post quarterly earnings at $1.07 per share on revenue of $386.91 million. Matrix Service Company (NASDAQ: MTRX) is estimated to post quarterly earnings at $0.07 per share on revenue of $285.16 million. Maiden Holdings, Ltd. (NASDAQ: MHLD) is projected to post quarterly earnings at $0.21 per share on revenue of $739.31 million. tronc, Inc. (NASDAQ: TRNC) is expected to post quarterly earnings at $0.65 per share on revenue of $428.25 million. Copa Holdings, - [By Douglas A. McIntyre]
Several large newspaper chains will face the largest increases in newsprint prices in absolute dollars. These are Gannett (NYSE: GCI), tronc (NASDAQ: TRNC), hedge fund owned Digital First Media, which just laid off dozens of people in Denver and on the West Coast, Hearst, Advance Media, McClatchy (NYSE: MNI) and Gatehouse Media. Among them, they own most of the large newspapers in America and hundreds of newspapers in aggregate. Each of these companies has newsprint demand much larger than that of The Tampa Bay Times.
- [By Douglas A. McIntyre]
Tronc Inc. (NASDAQ: TRNC), the owner of the Lost Angeles Times, agreed to sell the paper to billionaire Patrick Soon-Shiong, who is also one of Tronc’s largest shareholders. The deal, for $500 million and the assumption of about $90 million in pension liabilities, was announced on February 7. The Federal Trade Commission and U.S. Department of Justice blessed the deal on March 7, almost two months ago.
- [By Stephan Byrd]
News coverage about tronc (NASDAQ:TRNC) has trended somewhat positive recently, according to Accern. Accern identifies negative and positive press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. tronc earned a daily sentiment score of 0.03 on Accern’s scale. Accern also gave media headlines about the company an impact score of 47.3907920123643 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
- [By Douglas A. McIntyre]
Lewis D’Vorkin, the editor-in-chief of the L.A. Times, owned by Tronc Inc. (NASDAQ: TRNC), left the paper after contentious relations with his staff. According to The Wall Street Journal:
- [By Chris Hill]
Unemployment hits a 49-year low. Tech giants may have been hacked by China. Elon Musk's tweeting sends Tesla (NASDAQ:TSLA) shares lower. Costco (NASDAQ:COST) struggles with "material weakness." And Tronc (NASDAQ:TRNC) decides to change its name back to Tribune Publishing.
No comments:
Post a Comment